Sec Form 4 Filing - Apotheker Leo @ Burgundy Technology Acquisition Corp - 2020-09-18

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Apotheker Leo 2. Issuer Name and Ticker or Trading Symbol Burgundy Technology Acquisition Corp [ BTAQ.U] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Co-CEO (Last) (First) (Middle) C/O BURGUNDY TECHNOLOGY ACQUISITION CORP, PO BOX 1093, BOUNDARY HALL, CRICKET SQ 3. Date of Earliest Transaction (MM/DD/YY) 09/18/2020 (Street) GRAND CAYMAN, E9KY1-1102 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Ordinary Shares 09/18/2020 P 112,500 A 1,062,500 I See footnote ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant ( 1 ) ( 5 ) $ 11.5 09/18/2020 P 56,250 ( 3 ) ( 4 ) Class A Ordinary Shares 56,250 ( 1 ) 531,250 I See footnote ( 2 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Apotheker Leo C/O BURGUNDY TECHNOLOGY ACQUISITION CORP PO BOX 1093, BOUNDARY HALL, CRICKET SQ GRAND CAYMAN, E9KY1-1102 X X Co-CEO MacKey James Scott C/O BURGUNDY TECHNOLOGY ACQUISITION CORP PO BOX 1093, BOUNDARY HALL, CRICKET SQ GRAND CAYMAN, E9KY1-1102 X X Co-CEO, CFO & Secretary Burgundy Technology Sponsor Ltd C/O BURGUNDY TECHNOLOGY ACQUISITION CORP PO BOX 1093, BOUNDARY HALL, CRICKET SQ GRAND CAYMAN, E9KY1-1102 X Signatures /s/ Leo Apotheker 09/21/2020 Signature of Reporting Person Date /s/ James Scott Mackey 09/21/2020 Signature of Reporting Person Date /s/ James Scott Mackey, Director of Burgundy Technology Sponsor Limited 09/21/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes securities underlying units which, prior to the effectiveness of the registration statement relating to the issuer's public offering, Burgundy Technology Sponsor Limited (the "Sponsor") irrevocably committed to purchase. The purchase of these units is being made on a private placement basis with the second closing thereunder held simultaneously with the closing of the underwriters' exercise of the over-allotment option in full. 112,500 private placement units were acquired for an aggregate purchase price of $1,125,000. Each unit consists of one share of Class A ordinary share and one-half of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share. ( 2 )The Sponsor is the record holder of the shares and warrants reported herein. Messrs. Leo Apotheker and James Scott Mackey are shareholders of the Sponsor. Each of Messrs. Apotheker and Mackey disclaims beneficial interests of such shares and warrants except to the extent of his pecuniary interest therein. ( 3 )The warrants will become exercisable on the later of (a) 30 days after the issuer's completion of an initial business combination or August 31, 2021. ( 4 )The warrants will expire five years after the completion of the Issuer's initial business combination. ( 5 )Includes 56,250 warrants underlying the units referred to in footnote 1.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.